The link between different forms of HRT and breast cancer incidence
Re-analysis of potential breast cancer risks with both estrogen alone and combined HRT resulted in an alert being issued to healthcare professionals from the medical profession’s regulatory body (MHRA).
- IMS Statement 30.08.19 (PDF, 151KB)
- BMS response to Lancet paper (Word doc, 15KB)
The use of testosterone in the treatment of women
- IMS Key Messages (Word doc, 18KB)